Emergence of mycobacterium tuberculosis with extensive resistance to second-line drugs - Worldwide, 2000-2004

Morbidity and Mortality Weekly Report

Volumn 55, Issue 11, 2006, Pages 301-305

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; HEALTH; HUMAN; LATVIA; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; UNITED STATES;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; LATVIA; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; UNITED STATES; WORLD HEALTH;

EID: 33645119729     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Dooley SW, Jarvis WR, Martone WJ, Snider DE. Multidrug-resistant tuberculosis. Ann Intern Med 1992;117:257-9.
2. World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world: report no. 3. Geneva, Switzerland: World Health Organization; 2004.
3. Gupta R, Kim JY, Espinal MA, Caudron JM, Farmer PE, Raviglione MC. Responding to market failures in tuberculosis: a model to increase access to drugs and treatment. Science 2001;293:1049-51.
4. Laszlo A, Rahman M, Espinal M, et al. Quality assurance program for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/ IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002;6:748-56.
5. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005;9:640-5.
6. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, Switzerland: World Health Organization; 2006. (WHO/HTM/TB/2006.361).
7. Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis 1999;3:564-81.
8. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. N Engl J Med 1995;333:229-33.
9. Leimane V, Riekstina V, Holtz T, et al. Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005;365:318-26.
10. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348:119-28.